Medicure (MCUJF) Projected to Post Quarterly Earnings on Friday

Medicure (OTCMKTS:MCUJF) is expected to be releasing its results after the market closes on Friday, April 24th. Analysts expect Medicure to post earnings of ($0.0439) per share and revenue of $3.6210 million for the quarter.

Medicure Stock Performance

Medicure stock opened at $0.96 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.44 and a debt-to-equity ratio of 0.03. The firm has a 50-day moving average price of $0.84 and a two-hundred day moving average price of $0.84. The firm has a market capitalization of $10.06 million, a price-to-earnings ratio of -4.01 and a beta of 1.11. Medicure has a 52-week low of $0.60 and a 52-week high of $0.97.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.